drugset / Trial / NCT00663338

Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post Stroke

NCT00663338

NaSingle-groupDouble-blindTreatment

Summary

The aim of this study is to assess the effect of the drug rotigotine on the syndrome of hemispatial neglect and motor deficits following strokes affecting the right hemisphere of the brain.

Timeline

Start
2010-01
Primary completion
2010-06
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Rotigotine Unknown 9 mg Other

Indications

No indication recorded.